等待開盤 04-02 09:30:00 美东时间
0.000
0.00%
BRIEF-American Express Chairman And CEO Stephen J. Squeri Highlights The Company’S 2025 Performance And Position Of Strength In An Ai-Powered World In Letter To Shareholders American Express Co AXP.N : AMERICAN EXPRESS CHAIRMAN AND CEO STEPHEN J. SQUERI HIGHLIGHTS THE COMPANY’S 2025 PERFORMANCE AND
03-25 20:30
BRIEF-Unitedhealth - Amends Stock Option For Stephen Hemsley - SEC Filing Feb 25 (Reuters) - UnitedHealth Group Inc UNH.N : UNITEDHEALTH - AMENDS STOCK OPTION FOR STEPHEN HEMSLEY - SEC FILING UNITEDHEALTH - AMENDMENT ADDS TWO-YEAR SHARE HOLDING REQUIREMENT UNTIL MAY 2030 - SEC FILING Source text: []
02-25 19:25
BRIEF-RCL Says Samuel Minzberg To Become Board Chair Feb 19 (Reuters) - Reitmans Canada Ltd RETa.V : RCL ANNOUNCES BOARD LEADERSHIP TRANSITION REITMANS CANADA LTD - STEPHEN REITMAN TRANSITIONS TO BOARD DIRECTOR AND CHAIRMAN EMERITUS REITMANS CANADA LTD: SAMUEL MINZBERG TO BECOME BOARD CHAIR Source t
02-20 06:55
BRIEF-Nektar Therapeutics Announces Research Collaboration With Ucsf And Dr. Stephen Hauser For Nktr-0165 Feb 17 (Reuters) - Nektar Therapeutics NKTR.O : NEKTAR THERAPEUTICS ANNOUNCES RESEARCH COLLABORATION WITH UCSF AND DR. STEPHEN HAUSER FOR NKTR-0165, A TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) AN
02-17 20:27
BRIEF-Av Welcomes Stephen Voline As Senior Director, Washington Operations Feb 11 (Reuters) - AeroVironment Inc AVAV.O : AV WELCOMES STEPHEN VOLINE AS SENIOR DIRECTOR, WASHINGTON OPERATIONS Source text: ID:nBwRqZ41a Further company coverage: AVAV.O (( Reuters.Briefs@thomsonreuters.com ;))
02-11 20:45
BRIEF-Matthew J Saker Appointed Interim CEO Of Aureus Greenway Feb 3 (Reuters) - Aureus Greenway Holdings Inc AGH.O : AUREUS GREENWAY HOLDINGS INC - ON JAN 28, CHIPING CHEUNG RESIGNS AS CEO, PRESIDENT, AND DIRECTOR - SEC FILING AUREUS GREENWAY HOLDINGS INC - MATTHEW J. SAKER APPOINTED INTERIM CEO -
02-04 00:04
FDA Approves Johnson & Johnson's DARZALEX FASPRO Regimen for Newly Diagnosed Multiple Myeloma The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for
01-28 04:49
BRIEF-Customers Bank Appoints Stephen Wyremski As Chief Operating Officer Jan 26 (Reuters) - Customers Bancorp Inc CUBI.N : CUSTOMERS BANK APPOINTS STEPHEN WYREMSKI AS CHIEF OPERATING OFFICER Source text: ID:nBw7LZsMsa Further company coverage: CUBI.N (( Reuters.Briefs@thomsonreuters.com ;))
01-27 06:40
Dec 18 (Reuters) - 374Water Inc SCWO.O: 374WATER ANNOUNCES THE APPOINTMENT OF STEPHEN J. JONES AS CHAIRPERSON OF THE BOARD OF DIRECTORS AND CONCURRENT MANAGEMENT OPEN MARKET PURCHASES OF SCWO COMMON S...
2025-12-18 22:05
Dec 18 (Reuters) - Blackstone Inc BX.N: BLACKSTONE CEO STEPHEN SCHWARZMAN: LOOK FORWARD TO OTHER CUTS FROM THE U.S. FED -CNBC INTERVIEW BLACKSTONE CEO STEPHEN SCHWARZMAN: NUMBERS USED AS PART OF CPI S...
2025-12-18 21:53